Frontlight ResearchEarly access
Spinal muscular atrophy trials in Iran
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Not yet taking people in IranSPX-01 Gene Therapy in Pediatric Patients With Spinal Muscular Atrophy Type 1 (RISE)
- Where
- Tehran
- Age
- 1 day to 6 months
- People
- 1
- Run by
- Exir Gene Pharmed
See details and how to joinNCT07903376